{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:40:28Z","timestamp":1771951228325,"version":"3.50.1"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2013,3,6]],"date-time":"2013-03-06T00:00:00Z","timestamp":1362528000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0058051","type":"journal-article","created":{"date-parts":[[2013,3,7]],"date-time":"2013-03-07T01:47:45Z","timestamp":1362620865000},"page":"e58051","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Preclinical Demonstration of Synergistic Active Nutrients\/Drug (AND) Combination as a Potential Treatment for Malignant Pleural Mesothelioma"],"prefix":"10.1371","volume":"8","author":[{"given":"Viviana","family":"Volta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elia","family":"Ranzato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Martinotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Veronica","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciano","family":"Mutti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Biffo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Burlando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,3,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"14128","DOI":"10.1073\/pnas.0604544103","article-title":"Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and in causing mesothelioma in hamsters","volume":"103","author":"B Kroczynska","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrc2068","article-title":"A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes","volume":"7","author":"M Carbone","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ijc.23874","article-title":"Survival of pleural malignant mesothelioma in Italy: a population-based study","volume":"124","author":"F Montanaro","year":"2009","journal-title":"Int J Cancer"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ccm.2006.01.004","article-title":"Management of malignant pleural mesothelioma","volume":"27","author":"SD West","year":"2006","journal-title":"Clin Chest Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"61S","DOI":"10.1378\/chest.113.1_Supplement.61S","article-title":"Multimodality management of malignant pleural mesothelioma","volume":"113","author":"DJ Sugarbaker","year":"1998","journal-title":"Chest"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1517\/14728210903074563","article-title":"Malignant pleural mesothelioma: current treatments and emerging drugs","volume":"14","author":"C Belli","year":"2009","journal-title":"Expert Opin Emerg Drugs"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1556-0864(15)30366-X","article-title":"The use of chemotherapy in patients with advanced malignant pleural mesothelioma: a systematic review and practice guideline","volume":"1","author":"P Ellis","year":"2006","journal-title":"J Thorac Oncol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1200\/JCO.20005.14.589","article-title":"Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada","volume":"23","author":"JP van Meerbeeck","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1183\/09031936.00063109","article-title":"Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma","volume":"35","author":"A Scherpereel","year":"2010","journal-title":"Eur Respir J"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11864-011-0146-4","article-title":"The evolution of multimodality therapy for malignant pleural mesothelioma","volume":"12","author":"MG Zauderer","year":"2011","journal-title":"Curr Treat Options Oncol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/pros.20824","article-title":"Combination of vitamin E and selenium causes an induction of apoptosis of human prostate cancer cells by enhancing Bax\/Bcl-2 ratio","volume":"68","author":"S Reagan-Shaw","year":"2008","journal-title":"The Prostate"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/ijc.23689","article-title":"Vitamin E and cancer: An insight into the anticancer activities of vitamin E isomers and analogs","volume":"123","author":"C Constantinou","year":"2008","journal-title":"Int J Cancer"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"11105","DOI":"10.1073\/pnas.0804226105","article-title":"Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice","volume":"105","author":"Q Chen","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1073\/pnas.75.9.4538","article-title":"Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer","volume":"75","author":"E Cameron","year":"1978","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1165\/rcmb.2009-0340OC","article-title":"Selective ascorbate toxicity in malignant mesothelioma: a redox Trojan mechanism","volume":"44","author":"E Ranzato","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.tiv.2011.05.023","article-title":"In vitro screening of synergistic ascorbate-drug combinations for the treatment of malignant mesothelioma","volume":"25(8)","author":"S Martinotti","year":"2011","journal-title":"Toxicology in Vitro"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/sonc.2002.30232","article-title":"The role of gemcitabine in the treatment of malignant mesothelioma","volume":"29","author":"HL Kindler","year":"2002","journal-title":"Semin Oncol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1089\/acm.2005.11.521","article-title":"Medicinal benefits of green tea: Part I. Review of noncancer health benefits","volume":"11","author":"R Cooper","year":"2005","journal-title":"J Altern Complement Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nrc2641","article-title":"Cancer prevention by tea: animal studies, molecular mechanisms and human relevance","volume":"9","author":"CS Yang","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/carcin\/bgq039","article-title":"Pro-oxidative activities and dose-response relationship of (\u2212)-epigallocatechin-3-gallate in the inhibition of lung cancer cell growth: a comparative study in vivo and in vitro","volume":"31","author":"GX Li","year":"2010","journal-title":"Carcinogenesis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.tiv.2003.12.012","article-title":"Prooxidant property of green tea polyphenols epicatechin and epigallocatechin-3-gallate: implications for anticancer properties","volume":"18","author":"S Azam","year":"2004","journal-title":"Toxicol In Vitro"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1111\/j.1582-4934.2012.01584.x","article-title":"Epigallocatechin-3-gallate induces mesothelioma cell death via H<sub>2<\/sub>O<sub>2<\/sub>-dependent T-type Ca<sup>2+<\/sup> channel opening","volume":"16","author":"E Ranzato","year":"2012","journal-title":"J Cell Mol Med"},{"key":"ref23","first-page":"2055","article-title":"Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system","volume":"54","author":"WR Smythe","year":"1994","journal-title":"Cancer Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1183\/09031936.99.13352799","article-title":"Establishment of four new mesothelioma cell lines: characterization by ultrastructural and immunophenotypic analysis","volume":"13","author":"AM Orengo","year":"1999","journal-title":"Eur Respir J"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.lungcan.2004.04.027","article-title":"Aberrant E-cadherin and gamma-catenin expression in malignant mesothelioma and its diagnostic and biological relevance","volume":"45(1)","author":"S Orecchia","year":"2004","journal-title":"Lung Cancer"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/sj.onc.1207254","article-title":"Plakoglobin (gamma-catenin) has TCF\/LEF family-dependent transcriptional activity in beta-catenin-deficient cell line","volume":"23","author":"O Maeda","year":"2004","journal-title":"Oncogene"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"TC Chou","year":"1984","journal-title":"Adv Enzyme Regul"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1073\/pnas.0607542104","article-title":"Combination angiostatic therapy completely inhibits ocular and tumor angiogenesis","volume":"104","author":"MI Dorrell","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2307\/2531492","article-title":"Weighted Kaplan-Meier statistics: a class of distance tests for censored survival data","volume":"45","author":"MS Pepe","year":"1989","journal-title":"Biometrics"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1158\/1078-0432.CCR-07-1388","article-title":"Imatinib mesylate enhances therapeutic effects of gemcitabine in human malignant mesothelioma xenografts","volume":"14","author":"P Bertino","year":"2008","journal-title":"Clin Cancer Res"},{"key":"ref31","first-page":"3237","article-title":"Dual-color imaging of nascent angiogenesis and its inhibition in liver metastases of pancreatic cancer","volume":"26","author":"Y Amoh","year":"2006","journal-title":"Anticancer Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.bjc.6602720","article-title":"Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cells","volume":"93","author":"G Bocci","year":"2005","journal-title":"Br J Cancer"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.canlet.2008.10.001","article-title":"Suppression of androgen receptor signaling and prostate specific antigen expression by (\u2212)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cells","volume":"275","author":"CP Chuu","year":"2009","journal-title":"Cancer Lett"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.fct.2005.07.005","article-title":"Safety studies on epigallocatechin gallate (EGCG) preparations. Part 1: genotoxicity","volume":"44","author":"RA Isbrucker","year":"2006","journal-title":"Food Chem Toxicol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/07315724.2000.10718941","article-title":"Reevaluation of ascorbate in cancer treatment: emerging evidence, open minds and serendipity","volume":"19","author":"SJ Padayatty","year":"2000","journal-title":"J Am Coll Nutr"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.freeradbiomed.2009.02.016","article-title":"Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effects","volume":"47","author":"J Verrax","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jss.2011.06.058","article-title":"A murine xenograft model of spontaneous metastases of human lung adenocarcinoma","volume":"171(1)","author":"JE Harris Jr","year":"2011","journal-title":"J Surg Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1182\/blood.V93.1.268","article-title":"Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system","volume":"93","author":"J Dai","year":"1999","journal-title":"Blood"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1054\/drup.2001.0192","article-title":"Mitochondria as targets for established and novel anti-cancer agents","volume":"4","author":"JM Grad","year":"2001","journal-title":"Drug Resist Updat"},{"key":"ref40","first-page":"135","article-title":"Combined effect of cisplatin and 5-fluorouracil with irradiation on tumor cells in vitro","volume":"22","author":"B Nagy","year":"2002","journal-title":"Anticancer Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.freeradbiomed.2011.03.007","article-title":"Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer","volume":"50","author":"MG Espey","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"R8","DOI":"10.1186\/bcr2473","article-title":"(\u2212)-Epigallocatechin gallate sensitizes breast cancer cells to paclitaxel in a murine model of breast carcinoma","volume":"12","author":"T Luo","year":"2010","journal-title":"Breast Canc Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"9260","DOI":"10.1158\/0008-5472.CAN-06-1586","article-title":"(\u2212)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78","volume":"66","author":"SP Ermakova","year":"2006","journal-title":"Cancer research"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1478-3231.2009.01984.x","article-title":"Epigallocatechin-gallate modulates chemotherapy-induced apoptosis in human cholangiocarcinoma cells","volume":"29","author":"M Lang","year":"2009","journal-title":"Liver Int"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.3390\/ijms12095592","article-title":"Epigallocatechin-3-gallate (EGCG) for Clinical Trials: More Pitfalls than Promises?","volume":"12","author":"D Mereles","year":"2011","journal-title":"Int J Mol Sci"},{"key":"ref46","first-page":"269","article-title":"A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients","volume":"24","author":"HD Riordan","year":"2005","journal-title":"P R Health Sci J"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1631\/jzus.2005.B0446","article-title":"Pharmacokinetics of gemcitabine in Chinese patients with non-small-cell lung cancer","volume":"6","author":"LR Wang","year":"2005","journal-title":"J Zhejiang Univ Sci B"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.fct.2005.07.005","article-title":"Safety studies on epigallocatechin gallate (EGCG) preparations. Part 1: genotoxicity","volume":"44","author":"RA Isbrucker","year":"2006","journal-title":"Food Chem Toxicol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/sj.cgt.7700241","article-title":"Gene therapy of established mesothelioma xenografts with recombinant p16INK4a adenovirus","volume":"7","author":"SP Frizelle","year":"2000","journal-title":"Cancer Gene Ther"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"123","DOI":"10.7150\/jca.2.123","article-title":"In vivo imaging of human malignant mesothelioma grown orthotopically in the peritoneal cavity of nude mice","volume":"2","author":"M Feng","year":"2011","journal-title":"J Cancer"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0058051","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T09:16:35Z","timestamp":1595495795000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0058051"}},"subtitle":[],"editor":[{"given":"David L.","family":"McCormick","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,3,6]]},"references-count":50,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,3,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0058051","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,6]]}}}